Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹31 Cr₹30 Cr₹40 Cr₹11 Cr₹0.16 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹31 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹31 Cr
Mar2024₹30 Cr
Mar2023₹40 Cr
Mar2022₹11 Cr
Mar2021₹0.16 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹31 Cr
0.51
Mar2024 ₹30 Cr
-23.13
Mar2023 ₹40 Cr
272.42
Mar2022 ₹11 Cr
6,423.93
Mar2021 ₹0.16 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,021.7 Cr -2.2% 5.1% 114.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,402.0 Cr 1.2% -0.9% -1.8% Stock Analytics
DIVIS LABORATORIES ₹164,277.0 Cr 2.7% -3.8% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,140.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹107,398.0 Cr -0.1% -8.2% -8.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,378.0 Cr 2.7% 7.1% 2.8% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-2.2%

5.1%

114.8%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses